Title : Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.

Pub. Date : 2018 Jun 1

PMID : 29540601






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, off-label use of ribavirin (RBV) and polyethylene glycol-interferon (PEG-IFN) as antiviral therapy has shown promising results in both acute and chronic hepatitis E patients; however, the teratogenicity of RBV limits its use during pregnancy, while alpha IFN (IFN-alpha) increases the risk of transplant rejections. Ribavirin interferon alpha 1 Homo sapiens
2 Currently, off-label use of ribavirin (RBV) and polyethylene glycol-interferon (PEG-IFN) as antiviral therapy has shown promising results in both acute and chronic hepatitis E patients; however, the teratogenicity of RBV limits its use during pregnancy, while alpha IFN (IFN-alpha) increases the risk of transplant rejections. Ribavirin interferon alpha 1 Homo sapiens
3 Currently, off-label use of ribavirin (RBV) and polyethylene glycol-interferon (PEG-IFN) as antiviral therapy has shown promising results in both acute and chronic hepatitis E patients; however, the teratogenicity of RBV limits its use during pregnancy, while alpha IFN (IFN-alpha) increases the risk of transplant rejections. Ribavirin interferon alpha 1 Homo sapiens